Home › Funds › Triodos Investment Management BV › EW

Triodos Investment Management BV position in EW

EDWARDS LIFESCIENCES CORP · Health Care

Triodos Investment Management BV reported holding 548,358 shares of EW (EDWARDS LIFESCIENCES CORP) in its Q3 2026 13F filing — a position valued at US$47.3M, representing 2.89% of its reported portfolio and ranking #9 among its reported holdings. Triodos Investment Management BV has disclosed EW holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)548.36K sh
Reported value held$47.33M
Portfolio Weight2.89%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Triodos Investment Management BV's EW position evolved

Triodos Investment Management BV first disclosed a stake in EW in Q3 2023 at 374,258 shares (US$25.9M). The position peaked in Q3 2026 at 548,358 shares, worth US$47.3M. Across 13 filings, Triodos Investment Management BV increased the stake 3 time(s), trimmed it 4 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 548,358 shares valued at US$47.3M — an increase of 55,000 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 374.26K $25.93M New
Q4 2023 368.26K $28.08M Reduce
Q1 2024 407.96K $38.98M Add
Q2 2024 407.96K $37.68M Hold
Q3 2024 509.26K $33.61M Add
Q4 2024 509.96K $37.75M Hold
Q1 2025 507.76K $36.01M Hold
Q2 2025 509.26K $39.83M Hold
Q3 2025 508.86K $39.57M Hold
Q4 2025 504.86K $43.52M Reduce
Q1 2026 501.86K $40.19M Reduce
Q2 2026 493.36K $44.63M Reduce
Q3 2026 548.36K $47.33M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EW and 13F data

EW (EDWARDS LIFESCIENCES CORP) is a Health Care company. 31 other funds we track also report a position in EW — the largest reported positions include Belvedere Trading LLC (US$25.63B), DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt (US$1.18B), Ninety One UK Ltd (US$1.03B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EW

All EW fund holders →

FAQ

How long has Triodos Investment Management BV held EW?

Triodos Investment Management BV has disclosed EW holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Triodos Investment Management BV's current position in EW?

As of Q3 2026, Triodos Investment Management BV holds 548.36K shares of EW (EDWARDS LIFESCIENCES CORP), valued at $47.33M, representing 2.89% of its reported portfolio and ranking #9.

Has Triodos Investment Management BV been buying or selling EW?

In the latest 13F filing (Q3 2026), Triodos Investment Management BV increased its position in EW. The position peaked in Q3 2026 at 548.36K shares.

Which other funds hold EW?

Other major institutional holders of EW include Belvedere Trading LLC, DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt, Ninety One UK Ltd, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.